Searched over 200M research papers
10 papers analyzed
These studies suggest that gastric cancer staging involves multiple diagnostic tools such as staging laparoscopy, endoscopic ultrasound (EUS), multidetector CT (MDCT), and MRI, with EUS being particularly useful for T staging and staging laparoscopy for detecting peritoneal metastases, while treatment strategies vary from endoscopic resection in early stages to targeted therapies and neoadjuvant chemotherapy in advanced stages.
20 papers analyzed
Gastric cancer staging is a critical process in determining the appropriate treatment strategy and predicting patient outcomes. Accurate staging helps in assessing the extent of the disease, which is essential for planning surgical interventions and other therapies. This article synthesizes the latest research on various staging methods and their effectiveness in gastric cancer.
CT and EUS are commonly used imaging modalities for staging gastric cancer. EUS is particularly effective in local (T) staging, with studies showing it has a diagnostic accuracy ranging from 65% to 92.1% for overall T staging. EUS is superior to multidetector CT (MDCT) in preoperative T1 and N staging, although MDCT is more specific for M staging. However, both methods should be used cautiously for N staging due to insufficient data.
MRI is another promising tool for local staging, with sensitivity and specificity for assessing serosal involvement comparable to EUS and MDCT. However, fewer studies are available on MRI, making EUS the first-choice imaging modality for preoperative T staging.
Staging laparoscopy is a valuable diagnostic tool, especially for detecting peritoneal metastases. It has shown high accuracy, with an overall sensitivity of 84.6% and specificity of 100%. SL is particularly recommended for patients with locally advanced disease signs, as it provides accurate information about peritoneal dissemination and can be performed safely.
For curative-intent resection in advanced non-metastatic gastric cancer, a D2 lymph node dissection (LND) is preferred. Adequate staging requires the assessment of at least 16 lymph nodes. This approach ensures a more accurate staging and better patient outcomes.
All patients should be discussed at a multidisciplinary team meeting, and a staging CT of the chest and abdomen should always be performed. Diagnostic laparoscopy is recommended for patients at risk for stage IV disease. Laparoscopic resections should meet the same standards as open resections, and patients should be referred to higher volume centers for better management of potential complications.
The International Gastric Cancer Association (IGCA) has proposed a new stage grouping for the TNM classification, which better stratifies patient survival, especially among stage III subgroups. This new grouping is based on a large, worldwide data collection and aims to provide more accurate prognostic information.
Accurate staging of gastric cancer is essential for effective treatment planning and improving patient outcomes. EUS remains the preferred method for local staging, while staging laparoscopy is crucial for detecting peritoneal metastases. A multidisciplinary approach and adherence to recommended surgical techniques, including adequate lymph node assessment, are vital for optimal patient care. The proposed new TNM classification by the IGCA offers a promising improvement in staging accuracy and patient stratification.
Most relevant research papers on this topic